Male ageing is in focus nowadays. The aim of this study was to investigate conceptions of the male menopause (also known as andropause) in the educational and professional literature of Finnish physicians from 1982 to 2002, and the main point of interest was how the presentation of the male menopause and its treatments have changed. Published items for analysis were retrieved from the two main Finnish medical journals and from introductory gynaecology and urology textbooks using keywords for male ageing and hormones. It was found that disagreements about the male menopause have been marked. Some authors described it as a consequence of the decline in gonad functioning that comes with increased age, and some argued that we are making a disease out of normal ageing, but its association with sexual problems has risen in prominence: libido and potency disorders have recently been identified as symptoms. The treatment provided for male menopause was androgens, about which opinions diverged, especially the effect of androgen therapy on cardiovascular diseases and osteoporosis. New forms of testosterone treatment have been eagerly adopted, but opinions varied on the appropriate duration of the therapies. By the 2000s, the male menopause was increasingly likened to the female menopause, with emphasis upon the similar symptoms. While gerontological thinking largely sees the male menopause as an aspect of ageing and a normal condition, the andrological approach regards it as a treatable disease and its rapid adoption can be seen as a reflection of both private and public concerns about increased longevity.